The Pharmaceutical company Suven Life Sciences focuses on developing therapeutic drugs to treatment cognitive impairment associated with neurodegenerative disorders.
Three New Product Patents for Suven Life Sciences
Suven Life Sciences haas secured three product patents which are useful for treating neurodegenerative disorders.
Suven Life Sciences haas secured three product patents which are useful for treating neurodegenerative disorders.
Venkat Jasti, CEO of Suven Life Sciences, said, “We are very pleased by the grant of these patents to Suven for our pipeline of molecules in the CNS (central nervous system) arena that are being developed for cognitive disorders with high unmet medial need with huge market potential globally.”
The granted patents are exclusive intellectual property of Suven and the products out of these inventions may be out-licensed at various phases of clinical development.
Suven Life Sciences Starts Phase I Trial for Alzheimer�s Drug
Hyderabad-based Suven Life Sciences announced that it has started Phase I clinical trial of its experimental drug.
Hyderabad-based Suven Life Sciences announced that it has started Phase I clinical trial of its experimental drug.
Supreme Court to Deliver Key Drug Patent Ruling
On a patent challenge by Swiss drug giant Novartis that activists say threatens access to cheap generic versions of life-saving drugs in developing nations, India's Supreme Court is set to rule.
On a patent challenge by Swiss drug giant Novartis that activists say threatens access to cheap generic versions of life-saving drugs in developing nations, India's Supreme Court is set to rule.
Roche�s Cancer Drug Patent Partly Revoked in India
Roche confirmed that the Indian government has partly revoked the patents granted for its breast cancer drug Herceptin.
Roche confirmed that the Indian government has partly revoked the patents granted for its breast cancer drug Herceptin.
